Bayesian Capital Management, LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$146,832
-78.8%
13,800
-75.0%
0.02%
-84.5%
Q1 2022$693,000
+225.4%
55,100
+161.1%
0.10%
+123.9%
Q1 2020$213,000
+36.5%
21,100
+80.3%
0.05%
+70.4%
Q4 2019$156,000
-16.6%
11,700
-18.2%
0.03%
-75.9%
Q2 2016$187,00014,3110.11%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders